You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here. CHICAGO
CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology
At the ongoing American Society of Clinical Oncology (ASCO) Congress 2024, investigators revealed the Phase III HARMONi-A trial (NCT05184712) results of its PD-1/VEGF bispecific antibody
CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers applying for approval with data from trials solely run in
CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701
CHICAGO — People can be mightily reluctant to get a colonoscopy for reasons like cost, language barriers, or fear of what the exam might discover.
To encourage robust, good-faith discussion about issues raised in First Opinion, STAT publishes selected Letters to the Editor received in response to these essays. Submit
CHICAGO — Can there be another Keytruda? Merck CEO Rob Davis, whose company makes the $25 billion-a-year cancer medicine, says it … Sign up to
CHICAGO — Immunocore reported Friday that in an early-stage study, 56% of melanoma patients who received its experimental drug achieved disease control — a measurement
The FDA questioned data around Lykos Therapeutics’ MDMA-based therapy for post-traumatic stress disorder on Friday, less than a week before its advisory committee meets to